Signaturefd, LLC Collegium Pharmaceutical, Inc Transaction History
Signaturefd, LLC
- $5.2 Billion
- Q3 2024
A detailed history of Signaturefd, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Signaturefd, LLC holds 211 shares of COLL stock, worth $6,583. This represents 0.0% of its overall portfolio holdings.
Number of Shares
211
Previous 61
245.9%
Holding current value
$6,583
Previous $1,000
700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.6MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$181 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$82.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$73.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51.7 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.06B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...